A Safety and Dose Finding Study of Plasmin (Human) Administered Into the Middle Cerebral Artery of Stroke Patients

NCT01014975 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

BIOLOGICAL: Plasmin (Human)
BIOLOGICAL: Plasmin (Human)
BIOLOGICAL: Plasmin (Human)

Sponsor

Grifols Therapeutics LLC